Last month, HHS was working on an aggressive deadline. President Joe Biden had given them 45 days to develop a comprehensive plan to lower drug prices, and the clock was ticking. HHS asked stakeholders across the spectrum to provide input during a special roundtable discussion. Guess who they called from pharmacy?
Scott J. Knoer, MS, PharmD, FASHP, APhA EVP and CEO